Hong Kong · Delayed Price · Currency is HKD Kontafarma China Holdings Statistics
Total Valuation
HKG:1312 has a market cap or net worth of HKD 150.89 million. The enterprise value is 211.50 million.
| Market Cap | 150.89M |
| Enterprise Value | 211.50M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1312 has 5.59 billion shares outstanding.
| Current Share Class | 5.59B |
| Shares Outstanding | 5.59B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.90B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | 2.84 |
| P/OCF Ratio | 1.97 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.68, with an EV/FCF ratio of 3.98.
| EV / Earnings | -0.49 |
| EV / Sales | 0.23 |
| EV / EBITDA | 4.68 |
| EV / EBIT | n/a |
| EV / FCF | 3.98 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.80 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 4.50 |
| Debt / FCF | 3.83 |
| Interest Coverage | -4.17 |
Financial Efficiency
Return on equity (ROE) is -67.12% and return on invested capital (ROIC) is -7.31%.
| Return on Equity (ROE) | -67.12% |
| Return on Assets (ROA) | -2.12% |
| Return on Invested Capital (ROIC) | -7.31% |
| Return on Capital Employed (ROCE) | -7.45% |
| Weighted Average Cost of Capital (WACC) | 4.15% |
| Revenue Per Employee | 1.44M |
| Profits Per Employee | -672,717 |
| Employee Count | 636 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 4.53 |
Taxes
In the past 12 months, HKG:1312 has paid 27.83 million in taxes.
| Income Tax | 27.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.63% in the last 52 weeks. The beta is -0.02, so HKG:1312's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -15.63% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 36.44 |
| Average Volume (20 Days) | 1,420,275 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1312 had revenue of HKD 914.71 million and -427.85 million in losses. Loss per share was -0.08.
| Revenue | 914.71M |
| Gross Profit | 513.64M |
| Operating Income | -44.90M |
| Pretax Income | -454.73M |
| Net Income | -427.85M |
| EBITDA | -14.33M |
| EBIT | -44.90M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 66.06 million in cash and 203.68 million in debt, with a net cash position of -137.62 million or -0.02 per share.
| Cash & Cash Equivalents | 66.06M |
| Total Debt | 203.68M |
| Net Cash | -137.62M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 476.26M |
| Book Value Per Share | 0.10 |
| Working Capital | -90.79M |
Cash Flow
In the last 12 months, operating cash flow was 76.68 million and capital expenditures -23.52 million, giving a free cash flow of 53.15 million.
| Operating Cash Flow | 76.68M |
| Capital Expenditures | -23.52M |
| Depreciation & Amortization | 30.57M |
| Net Borrowing | -79.40M |
| Free Cash Flow | 53.15M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 56.15%, with operating and profit margins of -4.91% and -46.77%.
| Gross Margin | 56.15% |
| Operating Margin | -4.91% |
| Pretax Margin | -49.71% |
| Profit Margin | -46.77% |
| EBITDA Margin | -1.57% |
| EBIT Margin | -4.91% |
| FCF Margin | 5.81% |
Dividends & Yields
HKG:1312 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -283.55% |
| FCF Yield | 35.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 20, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Jan 20, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
HKG:1312 has an Altman Z-Score of 0.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 4 |